Inside PLAN8T: turning regulatory complexity into investable clarity

Sustainability regulation has gone from a compliance footnote to a board-level problem in the space of a few years. Frameworks like the EU Taxonomy now determine which products, processes and portfolios qualify as sustainable in a way that carries real commercial consequences — access to capital, eligibility for green financing, and increasingly, the ability to sell into markets that require proof, not intention.

The problem is that this regulatory landscape is expanding faster than most organisations can read it. For manufacturers trying to understand whether a product line qualifies, for planners specifying materials against sustainability criteria, and for financial institutions underwriting green portfolios, the underlying data exists — but it is scattered, inconsistently defined, and effectively unusable at the pace decisions now need to be made.

That gap is the opportunity PLAN8T was built to close.

The problem: unpriced complexity

Ask a manufacturer whether a given product conforms to the EU Taxonomy and, in most organisations, the honest answer is: it depends who you ask, and how long they have. The data required to answer the question with confidence — material composition, supply chain detail, lifecycle impact, design-stage decisions — usually exists somewhere inside the organisation. It rarely exists in a form that can be assessed, documented or defended quickly.

That unpriced complexity has a real cost. It slows down certification. It makes green financing harder to access. It leaves financial institutions unable to price the sustainability of what they are underwriting with any confidence. And critically, it pushes the conversation about circularity to the end of a product's life, when the decisions that actually determine circularity are made at the design stage.

The build: assembling what a business model needed

Regenovate's role was not to write a strategy document about this problem. It was to build a company that solves it commercially. That meant assembling three things that did not exist together before: the technical and data expertise to interpret regulatory frameworks at product level, the venture-building discipline to shape that capability into a business model, and the first strategic partnerships needed to validate it in the market.

PLAN8T took shape as a joint venture — bringing together data and regulatory expertise with the commercial structure needed to make the resulting product something organisations would pay for, not simply a tool they might use. The design principle behind it is straightforward: see, prove, act. Give leaders an accessible way to see where their products and processes stand against the taxonomy, generate the documentation needed to prove it — including toward formal certification — and use that clarity to act earlier, back at the design stage, where circularity is actually decided.

What's now true

PLAN8T's cockpit lets organisations assess a product portfolio against EU Taxonomy criteria, generate the documentation that certification processes require, and identify concretely where a product falls short of conforming — before that gap becomes a market or financing problem. What used to be a scattered, expensive, largely manual exercise becomes a repeatable, defensible one.

The commercial shift is the point. Regulatory complexity, on its own, is a cost centre — something organisations spend money to survive. Turned into investable clarity, it becomes a product manufacturers, planners and financial institutions actively pay for, because it answers a question they need answered regardless of their own sustainability ambitions: does this qualify, and can we prove it.

Why this case matters beyond PLAN8T

PLAN8T is a useful illustration of how we think about venture building generally. The opportunity did not start as a product idea. It started as a genuine gap between what regulation now demands and what organisations can currently deliver — and the work was building the team, the data foundation and the first partnerships needed to turn that gap into a company, rather than a diagnosis of the problem.

That is the pattern we look for across the portfolio: not a technology looking for a market, but a real, underserved need that becomes an investable business once someone does the work of building it properly.